SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001178913-15-002925
Filing Date
2015-09-22
Accepted
2015-09-22 07:01:09
Documents
6
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A zk1517359.htm 20-F/A 110505
2 EXHIBIT 4.39 exhibit_4-39.htm EX-4.39 266403
3 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 17543
4 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 16854
5 omega.jpg GRAPHIC 38823
6 bioline.jpg GRAPHIC 5830
  Complete submission text file 0001178913-15-002925.txt   474136
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-35223 | Film No.: 151118501
SIC: 2834 Pharmaceutical Preparations